Please login to the form below

Not currently logged in
Email:
Password:

Epanova

This page shows the latest Epanova news and features for those working in and with pharma, biotech and healthcare.

FDA approves AZ’s fish oil drug

FDA approves AZ’s fish oil drug

Epanova gets green light to reduce high levels of fat in the blood. ... Epanova is one of several pipeline-boosting drugs acquired by AZ over the past couple of years since Pascal Soriot took over as CEO.

Latest news

  • Teva launches first generic of GSK's Lovaza in US Teva launches first generic of GSK's Lovaza in US

    Also affected is AstraZeneca, which filed for approval of its own triglyceride-lowering drug Epanova last year. ... AZ acquired Epanova along with developer Omthera Pharmaceuticals in July 2013 in a $443m deal.

  • FDA to review AZ's fish oil drug Epanova FDA to review AZ's fish oil drug Epanova

    The US Food and Drug Administration (FDA) will assess Epanova for use in the treatment of patients with severe hypertriglyceridaemia – an excess of fatty molecules called triglycerides in the blood. ... At the time, Epanova was noted as the company's

  • AZ target Omthera files blood fat drug in US

    FDA submission for Epanova in severe hypertriglyceridemia. Omthera Pharmaceuticals said yesterday it had submitted its drug Epanova for US approval in the treatment of patients with high levels of the blood ... Epanova has one potential advantage over

  • AstraZeneca offers $443m to buy Omthera AstraZeneca offers $443m to buy Omthera

    If finalised, AZ will take control of the drug candidate Epanova, which has completed phase III testing and is ready for regulatory submissions to treat elevated blood triglycerides. ... Epanova is an omega-3 free fatty acid composition that has been

More from news
Approximately 4 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during May 2014 Pharma deals during May 2014

    One year ago AstraZeneca acquired Omthera. On May 7 Epanova, a soft gelation capsule containing Omega-3, was approved by the FDA as an adjunct to diet to reduce triglyceride levels

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics